The International Drug Policy Consortium, a grantee of the Open Society Institute Global Drug Policy Program, is a network of NGOs and professional networks that specialize in issues related to illegal drug use. The consortium aims to promote objective and open debate on the effectiveness, direction, and content of drug policies at national and international level, and supports evidence-based policies that are effective in reducing drug-related harm. It produces occasional briefing papers, disseminates the reports of its member organizations about particular drug related matters, and offers expert consultancy services to policymakers and officials around the world.
Consortium members have a wide range of experience and expertise in the analysis of drug policies, and have contributed to policy debates at national and international level. Several members have been involved in the creation or evaluation of drug policies and strategies in an official government or academic role. Following a review of available evidence, consortium members have agreed to promote five principles in their advocacy work with governments and international agencies.
The publication is available in English, Chinese, Farsi, French, and Russian.
Relevant drug policy publications are almost nonexistent in languages other than English. With the help of leading experts, the Global Drug Policy Program is publishing key documents in translation.
Read more
Harm Reduction
Every Overdose Death Is a Policy Failure

The U.S. state of Maine has seen tremendous reductions in overdose deaths, exceeding the national average. This reduction in overdose deaths is the direct result of decades of advocacy and strong policy reforms.
Harm Reduction for All
A Lifesaving Loan: A New Investment to Help Curb the U.S. Overdose Crisis

For over a decade, the small Remedy Alliance nonprofit has revolutionized providing lifesaving healthcare for people who use drugs. Our new investment will help the group increase access to the overdose antidote naloxone.
Drug Policy
Three Decades of Drug Policy Reform Work

Over the past 30 years, Open Society has been the largest philanthropic supporter of efforts to reform drug policy and promote harm reduction around the world. This is a timeline of the Foundations’ pathbreaking work.